INR 173.9
(1.28%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.53 Billion INR | 13.56% |
2022 | 1.34 Billion INR | 10.6% |
2021 | 1.21 Billion INR | -10.79% |
2020 | 1.36 Billion INR | -15.41% |
2019 | 1.61 Billion INR | 16.99% |
2018 | 1.37 Billion INR | 19.94% |
2017 | 1.15 Billion INR | 20.47% |
2016 | 955 Million INR | 12.13% |
2015 | 851.68 Million INR | 7.26% |
2014 | 794.06 Million INR | 32.23% |
2013 | 600.49 Million INR | -17.27% |
2012 | 725.83 Million INR | 9.6% |
2011 | 662.26 Million INR | -19.1% |
2010 | 818.58 Million INR | 204.76% |
2009 | 268.59 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q3 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 1.57 Billion INR | 0.0% |
2023 FY | 1.53 Billion INR | 13.56% |
2023 Q4 | 1.53 Billion INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 1.52 Billion INR | 0.0% |
2022 FY | 1.34 Billion INR | 10.6% |
2022 Q4 | 1.34 Billion INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2021 Q2 | 1.09 Billion INR | 0.0% |
2021 FY | 1.21 Billion INR | -10.79% |
2021 Q1 | - INR | -100.0% |
2021 Q4 | 1.21 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 Q4 | 1.36 Billion INR | 0.0% |
2020 FY | 1.36 Billion INR | -15.41% |
2020 Q2 | 1.5 Billion INR | 0.0% |
2019 Q4 | 1.61 Billion INR | 0.0% |
2019 Q2 | 1.61 Billion INR | 0.0% |
2019 FY | 1.61 Billion INR | 16.99% |
2018 FY | 1.37 Billion INR | 19.94% |
2018 Q4 | 1.37 Billion INR | 0.0% |
2017 FY | 1.15 Billion INR | 20.47% |
2016 FY | 955 Million INR | 12.13% |
2015 FY | 851.68 Million INR | 7.26% |
2014 FY | 794.06 Million INR | 32.23% |
2013 FY | 600.49 Million INR | -17.27% |
2012 FY | 725.83 Million INR | 9.6% |
2011 FY | 662.26 Million INR | -19.1% |
2010 FY | 818.58 Million INR | 204.76% |
2009 FY | 268.59 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ador Multiproducts Limited | 28.52 Million INR | -5263.191% |
Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | -39.117% |
Colgate-Palmolive (India) Limited | 13.22 Billion INR | 88.428% |
Cupid Limited | 186.52 Million INR | -720.267% |
Dabur India Limited | 48.19 Billion INR | 96.825% |
Emami Limited | 8.21 Billion INR | 81.387% |
Gillette India Limited | 8.59 Billion INR | 82.198% |
Godrej Consumer Products Limited | 58.97 Billion INR | 97.406% |
Hindustan Unilever Limited | 270.76 Billion INR | 99.435% |
Hipolin Limited | 48.57 Million INR | -3049.921% |
Honasa Consumer Limited | 5.36 Billion INR | 71.496% |
JHS Svendgaard Laboratories Limited | 271.7 Million INR | -463.113% |
Jyothy Labs Limited | 5.9 Billion INR | 74.099% |
Kaya Limited | 5.22 Billion INR | 70.703% |
Marico Limited | 32.52 Billion INR | 95.295% |
N.K Industries Limited | 22.4 Billion INR | 93.17% |
PAOS INDUSTRIES LIMITED | 163.96 Million INR | -833.11% |
Paramount Cosmetics (India) Limited | 205.72 Million INR | -643.717% |
Pee Cee Cosma Sope Limited | 80.17 Million INR | -1808.244% |
Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | 85.882% |